印度三级烧伤ICU临床分离菌的细菌学特征与耐药模式:碳青霉烯耐药与侵袭性感染的回顾性比较分析
结果显示碳青霉烯耐药率85.3%,侵袭性感染27.6%,总死亡率42.3%;TBSA%和侵袭是死亡的独立预测因素。
要点
- 烧伤ICU碳青霉烯耐药率高(85.3%),与更高TBSA%、更长住院和死亡显著相关。
- 侵袭性感染占27.6%,与碳青霉烯耐药和死亡均显著相关。
- TBSA%和侵袭是死亡的独立预测因素,需加强感染控制与抗菌药物管理。
核心结论
- 烧伤ICU患者碳青霉烯耐药和侵袭性感染高度流行,需加强感染控制、定期药敏监测和目标性抗菌药物管理。
主要发现
- 246例患者平均年龄29.1±20.4岁,平均TBSA%为39.0%±19.9%,总死亡率42.3%。
- 1586份样本培养出1057株病原体,以革兰阴性菌为主:铜绿假单胞菌36.1%、鲍曼不动杆菌22.3%、肺炎克雷伯菌18.8%。
- 85.3%患者存在碳青霉烯耐药,与更高TBSA%(P<.001)、更长住院(P=.022)和死亡(P<.001)显著相关。
- 侵袭性感染占27.6%,与碳青霉烯耐药和死亡均显著相关。
- 多因素logistic回归显示TBSA%(OR:1.07,P<.001)和侵袭(OR:4.14,P=.001)是死亡的独立预测因素。
临床怎么用
- 对烧伤ICU患者应常规开展药敏监测,尤其关注碳青霉烯耐药革兰阴性菌。
- 对高TBSA%和侵袭性感染患者应强化感染控制与目标性抗菌治疗。
局限性
- 回顾性单中心设计,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Burn injuries are a major cause of morbidity and mortality in low- and middle-income countries, with infections and antimicrobial resistance posing significant challenges. Carbapenem-resistant Gram-negative bacteria are particularly concerning in burn intensive care units. The aim of the study was to evaluate bacteriological profile, and antimicrobial susceptibility patterns of burn ICU patients, and identify risk factors associated with carbapenem resistance, invasive infections, and in-hospital mortality. This retrospective, single-center study included all patients admitted to a 30-bed burns ICU in north India between January and December 2024, whose clinical sample was received for microbiological investigations. Data on demographics, clinical parameters, and microbiological findings were extracted from hospital records and analyzed using chi-square, Fisher's exact, Mann-Whitney U tests, and multivariable logistic regression. Out of 246 patients included, the mean age was 29.1 ± 20.4 years and mean total body surface area (TBSA)% was 39.0% ± 19.9%. Overall mortality was 42.3%. A total of 1586 samples yielded 1057 pathogens, predominantly Gram-negative bacteria (Pseudomonas aeruginosa 36.1%, Acinetobacter baumannii 22.3%, and Klebsiella pneumoniae 18.8%). Carbapenem resistance was observed in 85.3% of patients and was significantly associated with higher TBSA% (P < .001), longer hospital stays (P = .022), and mortality (P < .001). Invasion was present in 27.6% and was significantly associated with both carbapenem resistance and mortality. Multivariable logistic regression identified TBSA% (odds ratio [OR]: 1.07, P < .001) and invasion (OR: 4.14, P = .001) as independent predictors of mortality. Carbapenem resistance and invasive infections are highly prevalent in burn ICU patients, underscoring the urgent need for robust infection control, regular antibiogram surveillance, and targeted antimicrobial stewardship in burn care settings.
引用
- Nityadarshini N, Biswas J, Singhal M, et al. Bacteriological Profile and Antimicrobial Resistance Patterns in Clinical Isolates From a Tertiary Burns ICU: A Retrospective Comparative Analysis of Carbapenem Resistance and Invasion. J Burn Care Res. 2026. PMID: 41051348. doi:10.1093/jbcr/iraf191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。